Cargando…

Key Considerations for the Development of Safe and Effective SARS‐CoV‐2 Subunit Vaccine: A Peptide‐Based Vaccine Alternative

COVID‐19 is disastrous to global health and the economy. SARS‐CoV‐2 infection exhibits similar clinical symptoms and immunopathological sequelae to SARS‐CoV infection. Therefore, much of the developmental progress on SARS‐CoV vaccines can be utilized for the development of SARS‐CoV‐2 vaccines. Caref...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shalash, Ahmed O., Hussein, Waleed M., Skwarczynski, Mariusz, Toth, Istvan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373118/ https://www.ncbi.nlm.nih.gov/pubmed/34176237 http://dx.doi.org/10.1002/advs.202100985

Ejemplares similares

The potential of developing a protective peptide‐based vaccines against SARS‐CoV‐2
por: Shalash, Ahmed O., et al.
Publicado: (2022)

Development of Multilayer Nanoparticles for the Delivery of Peptide-Based Subunit Vaccine against Group A Streptococcus
por: Kiong, Jolynn, et al.
Publicado: (2022)

The application of self-assembled nanostructures in peptide-based subunit vaccine development
por: Zhao, Guangzu, et al.
Publicado: (2017)

Oral Peptide Vaccine against Hookworm Infection: Correlation of Antibody Titers with Protective Efficacy
por: Shalash, Ahmed O., et al.
Publicado: (2021)

Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems
por: Shalash, Ahmed O., et al.
Publicado: (2022)

Peptide-based synthetic vaccines
por: Skwarczynski, Mariusz, et al.
Publicado: (2016)

Carbohydrate Immune Adjuvants in Subunit Vaccines
por: Bashiri, Sahra, et al.
Publicado: (2020)

Peptide-Based Subunit Vaccine against Hookworm Infection
por: Skwarczynski, Mariusz, et al.
Publicado: (2012)

Development of Polyelectrolyte Complexes for the Delivery of Peptide-Based Subunit Vaccines against Group A Streptococcus
por: Zhao, Lili, et al.
Publicado: (2020)

Progress in the Development of Subunit Vaccines against Malaria
por: Skwarczynski, Mariusz, et al.
Publicado: (2020)

Recent Advances in the Development of Peptide Vaccines and Their Delivery Systems against Group A Streptococcus
por: Azuar, Armira, et al.
Publicado: (2019)

Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines
por: Lu, Lantian, et al.
Publicado: (2021)

Polyacrylate–Peptide Antigen Conjugate as a Single-Dose Oral Vaccine against Group A Streptococcus
por: Faruck, Mohammad Omer, et al.
Publicado: (2020)

Cell-Penetrating Peptides: Efficient Vectors for Vaccine Delivery
por: Yang, Jieru, et al.
Publicado: (2019)

Cell-Penetrating Peptides-Based Liposomal Delivery System Enhanced Immunogenicity of Peptide-Based Vaccine against Group A Streptococcus
por: Yang, Jieru, et al.
Publicado: (2021)

Multiepitope Subunit Peptide-Based Nanovaccine against Porcine Circovirus Type 2 (PCV2) Elicited High Antibody Titers in Vaccinated Mice
por: Duong, Viet Tram, et al.
Publicado: (2023)

Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances
por: Zhang, Jiahui, et al.
Publicado: (2022)

Polyacrylate-GnRH Peptide Conjugate as an Oral Contraceptive Vaccine Candidate
por: Faruck, Mohammad O., et al.
Publicado: (2021)

Investigation of liposomal self-adjuvanting peptide epitopes derived from conserved blood-stage Plasmodium antigens
por: Islam, Md. Tanjir, et al.
Publicado: (2022)

Double conjugation strategy to incorporate lipid adjuvants into multiantigenic vaccines
por: Hussein, Waleed M., et al.
Publicado: (2016)

Detection and Quantification of SARS-CoV-2 Receptor Binding Domain Neutralization by a Sensitive Competitive ELISA Assay
por: Shalash, Ahmed O., et al.
Publicado: (2021)

Vaccination with Lipid Core Peptides Fails to Induce Epitope-Specific T Cell Responses but Confers Non-Specific Protective Immunity in a Malaria Model
por: Apte, Simon H., et al.
Publicado: (2012)

Development and Evaluation of a Cryopreserved Whole-Parasite Vaccine in a Rodent Model of Blood-Stage Malaria
por: Stanisic, Danielle I., et al.
Publicado: (2021)

Peptide Conjugation via CuAAC ‘Click’ Chemistry
por: Ahmad Fuaad, Abdullah A. H., et al.
Publicado: (2013)

Editorial: Advances in Vaccine Delivery: Adjuvants, Carriers, Formulations, and Routes
por: Skwarczynski, Mariusz
Publicado: (2022)

Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines
por: Ssemaganda, Aloysious, et al.
Publicado: (2019)

The Development of Surface-Modified Liposomes as an Intranasal Delivery System for Group A Streptococcus Vaccines
por: Yang, Jieru, et al.
Publicado: (2023)

Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2
por: Kalita, Parismita, et al.
Publicado: (2020)

Vaccines and Vaccination against SARS-CoV-2: Considerations for the Older Population
por: Weinberger, Birgit
Publicado: (2021)

Plant-made poliovirus vaccines – Safe alternatives for global vaccination
por: Bolaños-Martínez, Omayra C., et al.
Publicado: (2022)

SARS-CoV-2 vaccine safe for young patients
por: Onuora, Sarah
Publicado: (2022)

Poly(hydrophobic Amino Acids) and Liposomes for Delivery of Vaccine against Group A Streptococcus
por: Azuar, Armira, et al.
Publicado: (2022)

Advances in Infectious Disease Vaccine Adjuvants
por: Fan, Jingyi, et al.
Publicado: (2022)

Designing a conserved peptide-based subunit vaccine against SARS-CoV-2 using immunoinformatics approach
por: Oladipo, Elijah Kolawole, et al.
Publicado: (2021)

CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immune responses against SARS-CoV-2
por: Laotee, Sedthawut, et al.
Publicado: (2023)

Neurology and vaccinations: considerations in the context of COVID-19/SARS-COV-2
por: Cauchi, M., et al.
Publicado: (2021)

Development of a Recombinant RBD Subunit Vaccine for SARS-CoV-2
por: Sun, Yi-Sheng, et al.
Publicado: (2021)

Protective immunity induced by an inhaled SARS-CoV-2 subunit vaccine
por: Elder, Elizabeth, et al.
Publicado: (2023)

Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines?
por: Tiboni, Mattia, et al.
Publicado: (2021)

Induction of high titred, non-neutralising antibodies by self-adjuvanting peptide epitopes derived from the respiratory syncytial virus fusion protein
por: Jaberolansar, Noushin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cb3dpf3acdelohru6fjfr7pg5q